Immunohistochemical detection of BRCA1 mutation and cerbB-2 amplification in breast cancer patients with positive history

被引：0
|
作者：
Ravazoula, Panagiota [1 ]
Gkermpesi, Maria [1 ]
Zyli, Paraskeyi [1 ]
Liava, Anna [1 ]
Aletra, Christina [1 ]
机构：
[1] Univ Hosp, Patras, Greece
来源：
VIRCHOWS ARCHIV | 2007年 / 451卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [11] Mutation analysis of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
    Steinmann, D
    Bremer, M
    Rades, D
    Stuhrmann, M
    Schmidtke, J
    Karstens, JH
    Dörk, T
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (04): : B11 - B11
  • [12] SECOND BREAST CANCER RISK IN BRCA1 AND BRCA2 MUTATION CARRIERS PATIENTS
    Palazzo, A.
    Iacovelli, R.
    Trenta, P.
    Sidoni, T.
    Ricevuto, E.
    Naso, G.
    Giannini, G.
    Gulino, A.
    Cortesi, E.
    De Marchis, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 33 - 33
  • [13] Predictors of survival for breast cancer patients with a BRCA1 mutation
    Narod, Steven A.
    Huzarski, Tomasz
    Gronwald, Jacek
    Byrski, Tomasz
    Marczyk, Elzbieta
    Cybulski, Cezary
    Szwiec, Marek
    Wisniowski, Rafal
    Birkenfeld, Bozena
    Kilar, Ewa
    Sibilski, Robert
    Sun, Ping
    Lubinski, Jan
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 513 - 521
  • [14] Predictors of survival for breast cancer patients with a BRCA1 mutation
    Steven A. Narod
    Tomasz Huzarski
    Jacek Gronwald
    Tomasz Byrski
    Elzbieta Marczyk
    Cezary Cybulski
    Marek Szwiec
    Rafal Wisniowski
    Bozena Birkenfeld
    Ewa Kilar
    Robert Sibilski
    Ping Sun
    Jan Lubinski
    Breast Cancer Research and Treatment, 2018, 168 : 513 - 521
  • [15] Diagnosis and treatment of patients with breast cancer and mutation in the BRCA1/2 genes
    Kufel-Grabowska, Joanna
    Wasag, Bartosz
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (03): : 222 - 228
  • [16] Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)
    Eerola, H
    Pukkala, E
    Pyrhönen, S
    Blomqvist, C
    Sankila, R
    Nevanlinna, H
    CANCER CAUSES & CONTROL, 2001, 12 (08) : 739 - 746
  • [17] Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)
    Hannaleena Eerola
    Eero Pukkala
    Seppo Pyrhönen
    Carl Blomqvist
    Risto Sankila
    Heli Nevanlinna
    Cancer Causes & Control, 2001, 12 : 739 - 746
  • [18] Breast cancer detection among Irish BRCA1 and BRCA2 mutation carriers.
    Walsh, Elaine
    Farrell, Michael P.
    Gallagher, Fergal
    Clarke, Roisin
    Kennedy, Carmel Nolan M. John
    Daly, Peter
    McCaffrey, John
    Connolly, Elizabeth M.
    Boyle, Terence
    Kell, Malcolm R.
    O'Keefe, Sylvia
    Gallagher, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [19] Breast cancer detection among Irish BRCA1 and BRCA2 mutation carriers.
    Walsh, Elaine
    Farrell, Michael P.
    Gallagher, Fergal
    Clarke, Roisin
    Nolan, Carmel
    Kennedy, M. John
    Daly, Peter
    McCaffrey, John
    Connolly, Elizabeth M.
    Boyle, Terence
    Kell, Malcolm R.
    Gallagher, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [20] Immunohistochemical features of breast cancer patients with BRCA1 mutation: First experience from Eastern India
    Chakraborty, A.
    Basak, J.
    Chaudhuri, K.
    Katarkar, A.
    Mukhopadhyay, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S113 - S113
12345